This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Goldman Sachs-Sojitz JV among deals unconditionally cleared in China June 27-July 3

( July 5, 2022, 01:50 GMT | Official Statement) -- MLex Summary: A joint venture between investment banking company Goldman Sachs and Japanese trading house Sojitz; Atnahs Pharma UK’s acquisition of the synthetic vitamins business unit of Swiss healthcare company F. Hoffmann-La Roche; and State Power Investment Corporation’s purchase of a 70 percent stake each in Marangatu Holding and Panati Holding are among the 23 deals that received unconditional antitrust approval from China’s State Administration for Market Regulation between June 27 and July 3, according to a list of deals published by the regulator.The list of deals is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections